Latest Breaking News On - Marijuana patients - Page 1 : comparemela.com

FL Gov Vetoes Hemp Bill, Dutch Panel Recommends MDMA for PTSD, More (6/10/24)

FL Gov Vetoes Hemp Bill, Dutch Panel Recommends MDMA for PTSD, More (6/10/24)
stopthedrugwar.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stopthedrugwar.org Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBritish columbiaCristina castroPia dijkstraBrittany mapleKali sedgemoreBryant cafferelliRon desantisDepartment of consumer protectionDepartment of childrenBc supreme courtMatsqui abbotsford impact societyCoalition of peers dismantling the drug warDutch panel recommendsHealth canada

Pa law protects workers approved for medical marijuana — but once they use it, it s a different story | Weed | Pittsburgh

Fired workers and frustrated employers are facing off in court battles over Pennsylvania’s vague safeguards for marijuana patients, and those on both sides are asking for a legislative fix.

United statesLancaster countyCity of philadelphiaMifflin countyNorthumberland countyJoseph clark jrBob menschRichard barnesJudith casselAlex halperTodd eachusRobert moyerTodd douglasBlake longeneckerJudy schwankJohn mccreary jr

Transcripts for CNN Weed 3 The Marijuana Revolution 20151107 08:19:00

it may be the anti-inflammatory effects or even the dulling of pain receptors. regardless, this study could prove to mainstream medicine what millions of marijuana patients already believe. that a plant may be a better pain treatment than the powerful pills that are most commonly prescribed. do we ever get to a point where we say, look, it s a medicine like so many other medicines out there? i always used to say not in my lifetime, but now i m becoming more cautious because who knows. let s just wait and see. wait and see, that s been a mantra for decades when it comes to pot. but for rick doblin and his veterans, the time for waiting is over. yet they re about to be faced with shocking news that could

Mainstream medicinePain receptorsMarijuana patientsSpain treatmentRick doblin

Transcripts for CNN Weed 3 The Marijuana Revolution 20150425 05:19:00

common use for medical marijuana. it may be the anti-inflammatory effects or even the dulling of pain receptors. regardless, this study could prove to mainstream medicine what millions of marijuana patients already believe. that a plant may be a better pain treatment than the powerful pills that are most commonly prescribed. do we ever get to a point where we say, look, it s a medicine like so many other medicines out there? i was just going to tell you, i always used to say not in my life time. but now i m becoming a little more cautious because who knows. let s just wait and see. wait and see, that s been a mantra for decades when it comes to pot. but for rick doblin and his veterans, the time for waiting is over. yet they re about to be faced with shocking news that could put the whole ptsd study in jeopardy. we all enter this world

Mainstream medicineMarijuana patientsSpain treatmentPain receptorsRick doblin

Transcripts for CNN Weed 3 The Marijuana Revolution 20150425 02:19:00

treating pain is the most common use for medical marijuana. it may be the antiinflam tory effects or even the dulling of pain receptors. regardless, this study could prove to mainstream medicine what millions of marijuana patients already believe. that a plant may be a better pain treatment than the powerful pills that are most commonly prescribed. do we ever get to a point where we say, look, it s a medicine like so many other medicines out there? i always used to say not in my lifetime, but now i m becoming more cautious because who knows. let s just wait and see. wait and see, that s been a mantra for decades when it comes to pot. but for rick doblin and his patients, the time to wait is over. yet they re about to be faced with shocking news that could put the whole ptsd study in jeopardy.

Antiinflam tory effectsMainstream medicineMarijuana patientsSpain treatmentPain receptorsRick doblin